ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Christophe Guignabert^{1

2}, Frances de Man³, Marc Lombès^{2

4

5}

Affiliations

¹ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
² Faculté de Médecine, Université Paris-Sud and Université Paris Saclay, Le Kremlin-Bicêtre, France.
³ Dept of Pulmonology, Amsterdam Cardiovascular Sciences, VU University Medical Center, Amsterdam, The Netherlands.
⁴ INSERM UMR_S 1185, Le Kremlin-Bicêtre, France.
⁵ Service d'Endocrinologie et des Maladies de la Reproduction, Hôpitaux Universitaires Paris-Sud, CHU Bicêtre, AH-HP, Le Kremlin Bicêtre, France.

PMID: 29929959
DOI: 10.1183/13993003.00848-2018

Free article

Editorial

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Christophe Guignabert et al. Eur Respir J. 2018.

Free article

. 2018 Jun 21;51(6):1800848.

doi: 10.1183/13993003.00848-2018. Print 2018 Jun.

Authors

Christophe Guignabert^{1

2}, Frances de Man³, Marc Lombès^{2

4

5}

Affiliations

¹ INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, France.
² Faculté de Médecine, Université Paris-Sud and Université Paris Saclay, Le Kremlin-Bicêtre, France.
³ Dept of Pulmonology, Amsterdam Cardiovascular Sciences, VU University Medical Center, Amsterdam, The Netherlands.
⁴ INSERM UMR_S 1185, Le Kremlin-Bicêtre, France.
⁵ Service d'Endocrinologie et des Maladies de la Reproduction, Hôpitaux Universitaires Paris-Sud, CHU Bicêtre, AH-HP, Le Kremlin Bicêtre, France.

PMID: 29929959
DOI: 10.1183/13993003.00848-2018

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Comment on

Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension.
Baird GL, Archer-Chicko C, Barr RG, Bluemke DA, Foderaro AE, Fritz JS, Hill NS, Kawut SM, Klinger JR, Lima JAC, Mullin CJ, Ouyang P, Palevsky HI, Palmisicano AJ, Pinder D, Preston IR, Roberts KE, Smith KA, Walsh T, Whittenhall M, Ventetuolo CE. Baird GL, et al. Eur Respir J. 2018 Jun 28;51(6):1800467. doi: 10.1183/13993003.00467-2018. Print 2018 Jun. Eur Respir J. 2018. PMID: 29954925 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Affiliations

ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Research Materials